InnovaQor: The Qira Offering Can Revolutionize The Analytics Process For HCOs

We have extensively covered InnovaQor (OTCPK:VMCS) in the past as one of the most undervalued healthcare-tech microcaps with a wide variety of offerings for certified healthcare organizations (HCOs). The company is expected to benefit heavily from the growing healthcare IT spending, and changes and improvements in network connectivity. While InnovaQor has a long list of offerings, each of which is a ground-breaking innovation in its domain, we believe that its analytics-based offering, Qira, has some excellent growth potential in the near term, particularly with small and medium-sized HCOs.

InnovaQor Recap

InnovaQor is a Florida-based technology small-cap catering healthcare and laboratory customers in the U.S. with information technology solutions and services. Its has a wide set of offerings which include Medical Mime, an EHR (electronic health record) and patient management tool; ClinLab, a turnkey client or server lab data system for mid-range research laboratory; M2Pro, a customizable, cloud-based, electronic health tracking device for ambulatory physician practices; and most importantly, Qira, a healthcare business analytics tool that is changing the way HCOs do business. The company also offers IT-managed services, and provides medical support services largely to corporate operations, behavioral health facilities, rural hospitals, and physician offices.

What Is HTS Qira?

Qira falls within the Healthcare Technology Solutions (HTS) offerings of InnovaQor. This analytics-based offering essentially caters to small and medium-sized HCOs and connects different data sources across an entire health care company, to enhance services, reporting, and financial health. Qira has been developed to have a highly engaging graphic display that helps combine and simplify complex information making it understandable for all levels of healthcare end-users. In fact, it is known to aptly summarize complex data points and bring it down to a granular analysis of individual line items for simplicity. This is made possible by performing complex computations on massive data sets. It provides end users with the ability to customize what they would like to see in any given visual (dashboard) based on any number of slicers and filters. Moreover, users can easily extract the relevant data into any Microsoft Office application and analyze it further or prepare reports. The platform is accessible from all forms of hardware whether it is computers or mobile phones. Qira makes user data accessible wherever any customer is using Microsoft's PowerBI platform.

Why Is Qira Such A Game Changer For HCOs?

Existing software providers for the healthcare sector provide the occasional bolt-on custom-built analytics solution as a part of their existing software to clients to help them work with a specific data set. As such, healthcare companies are often limited to only the data that is generated by a single-system being accessible via any given dashboard. This is a problem as most healthcare companies use not one but a suite of applications that may be sourced from many different developers. This forces healthcare companies to either adopt a single-system solution. However, these have their own share of problems as they may underperform at any point in the process. Many smaller HCOs often end up abandoning or generally disregarding analytic tools due to the limitations of their scope. This has created a wide market for an offering like Qira. Given its analytics capabilities and its flexibility, Qira can consume, transform, and aggregate data from any system into a single, end-to-end view of a process. The fact that it is an independent analytics tool with such flexibility is helping its customers feel empowered to choose the ideal software that meets their needs at each step of their claims process.

Final Thoughts

As we can see in the above chart, InnovaQor’s stock price has been volatile but the stock is priced very cheaply at $0.005. Qira’s vast application in the small and medium-sized HCO market alone could result in the company’s revenues growing exponentially. Let us not forget that the company also has other solid offerings like Medical Mime, ClinLab, and vCIO services which are all high-quality offerings for HCOs too. Overall, we continue to be bullish on InnovaQor and we believe that there is a strong upside for the shareholders of this company.

Disclaimer

This website is a wholly owned subsidiary of SCD Media, LLC, herein referred to as Smallcaps Daily. Our publications are a commercial advertisement and are for general information purposes ONLY. We are engaged in the business of marketing and advertising companies for monetary compensation. We may receive compensation for this article on a PPC basis as an affiliate. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our services, joining our site or our email/blog list as well as any social networking platforms we may use. PLEASE NOTE WELL: Smallcaps Daily and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever.Release of Liability: Through use of this website viewing or using you agree to hold Smallcaps Daily, its operators owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Smallcaps Daily encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and Smallcaps Daily makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies. None of the materials or advertisements herein constitute offers or solicitations to purchase or sell securities of the companies profiled herein and any decision to invest in any such company or other financial decisions should not be made based upon the information provided herein. Instead Smallcaps Daily strongly urges you conduct a complete and independent investigation of the respective companies and consideration of all pertinent risks. Readers are advised to review SEC periodic reports: Forms 10-Q, 10K, Form 8-K, insider reports, Forms 3, 4, 5 Schedule 13D. Smallcaps Daily is compliant with the Can Spam Act of 2003. Salesparq, LLC does not offer such advice or analysis, and Smallcaps Daily further urges you to consult your own independent tax, business, financial and investment advisors. Investing in micro-cap and growth securities is highly speculative and carries and extremely high degree of risk. It is possible that an investors investment may be lost or impaired due to the speculative nature of the companies profiled. The Private Securities Litigation Reform Act of 1995 provides investors a safe harbor in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements indicating certain actions & quote; may, could, or might occur. Understand there is no guarantee past performance will be indicative of future results.In preparing this publication, Smallcaps Daily, has relied upon information supplied by its customers, publicly available information and press releases which it believes to be reliable; however, such reliability cannot be guaranteed. Investors should not rely on the information contained in this website. Rather, investors should use the information contained in this website as a starting point for doing additional independent research on the featured companies. Smallcaps Daily has not been compensated for this article. The advertisements in this website are believed to be reliable, however, Smallcaps Daily and its owners, affiliates, subsidiaries, officers, directors, representatives and agents disclaim any liability as to the completeness or accuracy of the information contained in any advertisement and for any omissions of materials facts from such advertisement. Smallcaps Daily is not responsible for any claims made by the companies advertised herein, nor is Smallcaps Daily responsible for any other promotional firm, its program or its structure. Smallcaps Daily is not affiliated with any exchange, electronic quotation system, the Securities Exchange Commission or FINRA.